Company Active LTD

Company profile

Invibio Limited

Invibio Biomaterial Solutions - Advancing Implantable Devices

PEEK-OPTIMA polymers are widely used in a range of implantable medical implant used by surgical healthcare professionals. Click here to find why.

CRN
04088050
Founded
2000
Age
25

Overview

Legal name
INVIBIO LIMITED
Region
North West England
Registered address
VICTREX TECHNOLOGY CENTRE HILLHOUSE INTERNATIONAL
THORNTON
CLEVELEYS
LANCASHIRE
FY5 4QD
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

1 level 1 ultimate controller Controls 3
1
Company Active LTD
Invibio Limited
CRN 04088050
2
Direct and ultimate controller Active PLC
Victrex PLC
CRN 02793780

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Jun
2027

Accounts due

Accounts Due

Next accounts due date

24 Dec
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

10 Dec
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Sep
2025

Accounts filed

Accounts

Last accounts made up date

17 Oct
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQzOTkzMTg2MGFkaXF6a2N4

Published 17 Oct 2024 09:40

11 Oct
2000

Incorporated

Inception

Company registered at Companies House

Public funding

5 awards
First funded
2008
Funded years
2008, 2009, 2011, 2018
Age at first award
7 years

Projects

2018 Knowledge Transfer Partnership

Aston University and Invibio Limited

1 Nov 2018 to 31 Oct 2021

Awarded
Unknown

To develop evaluation procedures to determine the mechanisms and effects of particulate debris from Carbon Fibre Reinforced PEEK fracture fixation devices, which will enable increased adoption of this material for use in orthopaedic trauma procedures.

2011 Knowledge Transfer Partnership

University of Bradford And Invibio Limited

1 Oct 2011 to 31 Oct 2013

Awarded
Unknown

To process innovation in the field of implantable polyaryletheretherketone (PEEK) micromoulding and to transfer the knowledge generated throughout the technical staff.

2011 Collaborative R&D

High value manufacturing of PEEK composite orthopedic implants

1 Aug 2011 to 31 Jul 2014

Awarded
£209,052
Total cost £418,104

The primary objective of this collaborative research project is to develop low cost, PEEK composite intramedullary (IM) nails for pre-clinical evaluation in an ovine tibial fracture model to determine whether an implant modulus of elasticity closer to bone would encourage faster healing through reduced stress shielding and increased micromotion. Although ...

2009 Collaborative R&D

SHIELD

1 Oct 2009 to 30 Nov 2012

Awarded
£102,835
Total cost £233,716

Acetabular and femoral bone resorption is one of the few remaining clinical challenges to be addressed when considering the long term success of orthopaedic joint replacements, particularly in hip prostheses. Bone resorption around the proximal femoral stem and acetabular cup due to stress shielding contributes to bone loss and reduced bone mineral densit...

2008 Collaborative R&D

High Performance Liquid Crystalline Bioresorbable Polymers

1 Jan 2008 to 31 Dec 2010

Awarded
£425,375
Total cost £850,752

Awaiting Public Summary

Product types

Collaborative R&D Knowledge Transfer Partnership